Clinical Trial Update: Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of RAD001 (everolimus) in patients with operable non-small cell lung cancer has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RAD001 (everolimus)

Snippet

Sponsor: Emory University | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-07-14